Pharmaceuticals, Biotechnology and Life Sciences
Xcenda,a part of AmerisourceBergen, today announced the acquisition ofDymaxium, a trusted market access partner specializing in the exchangeof evidence and information between payers and life science companiesthrough its FormularyDecisions.com® platform.
Japanese government organization to train reviewers to efficiently analyze PBPK model submissions LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), the…
Firm Announces Dr. Midthun as Principal, Drug and Biological Products WASHINGTON–(BUSINESS WIRE)–Greenleaf Health, Inc. (Greenleaf), a leading Food and Drug…
Leading biopharmaceutical organizations join Project Baseline initiative to engage more patients and clinicians in research and speed evidence generation SAN…
AUSTIN, Texas & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company, today announced it will be presenting…
DUBLIN–(BUSINESS WIRE)–The “US Breast Cancer Drug Market, Price, Dosage & Clinical Pipeline Insight 2025” drug pipelines has been added to…
Acquisition Includes Novel Late-Stage Renal Cell Carcinoma Candidate, PT2977 KENILWORTH, N.J. & DALLAS–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24MRK&src=ctag" target="_blank"gt;$MRKlt;/agt; lt;a href="https://twitter.com/hashtag/MRK?src=hash" target="_blank"gt;#MRKlt;/agt;–Merck (NYSE:…
Shipments for Follow-on Order Under Existing Supply Agreement Will Commence This Quarter STONY BROOK, N.Y.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24apdn&src=ctag" target="_blank"gt;$apdnlt;/agt; lt;a href="https://twitter.com/hashtag/PCR?src=hash"…
Data Supports Continued Dose Escalation and Further Investigation in Metastatic Renal Cell Carcinoma (mRCC) MAINZ, Germany–(BUSINESS WIRE)–EXUMA Biotechnology and affiliate…
Completion of Gene-to-Lead phase for first discovery project targeting METTL3/METTL14 complex NEW YORK & LEIDEN, Netherlands–(BUSINESS WIRE)–Gotham Therapeutics, a biotechnology…